Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Thrombotic Microangiopathy in Interferon-Beta-Treated Multiple Sclerosis Patient Publisher



Malekzadeh MM1 ; Alizadeh R2 ; Aghsaeifard Z3, 4 ; Sahraian MA5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Digestive Disease Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Anesthesiology and Intensive Care, AJA University of Medical Sciences, Tehran, Iran
  3. 3. Department of Internal Medicine, School of Medicine Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Clinical Case Reports Published:2020


Abstract

A 43-year-old man who was treated with interferon-beta for multiple sclerosis was presented with hypertension, headache, nausea/vomiting, blurred vision, and renal dysfunction. The treatment with drugs and dialysis relieved the symptoms. Despite plasmapheresis is known to cause improvement in renal function, no such improvement was seen in patient. © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.